openPR Logo
Press release

Xerostomia Therapeutics Market to Show Significant Growth Along with Major Leading Players: Eisai Inc., Colgate-Palmolive Company, Dentaid, EUSA Pharma, Forward Science, GlaxoSmithKline plc and Mission Pharmacal Company

11-05-2018 10:38 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Xerostomia Therapeutics Market

Xerostomia Therapeutics Market

Overview: -

Xerostomia is also defined as dry mouth condition causing due to absent or reduced saliva. In general, xerostomia is not considered as a disorder, but it is a condition with symptom associated with various medical situations such as a side effect of a radioactivity to the head and neck generally during chemotherapy or a side effect of a number of medications. It may or may not be associated with decreased salivary gland function. Xerostomia is a common problem majorly observed in geriatric population affecting around 20% of the individuals. However, xerostomia does not act to be age-related disorder itself as xerostomia is generally caused as a side effect.

Xerostomia Therapeutics Market Size is anticipated to reach over USD 822.14 million by 2026 according to a new research published by Polaris Market Research.

Request Sample Pages for more Professional and Technical insights @
http://bit.ly/2PKwMHc

Growth Factors and Key Vendors: -

The rise in favorable reimbursement scenario for xerostomia products and growing awareness about related with ailments are the major factors contributing the Xerostomia Therapeutics Market growth. Moreover, growing occurrence of xerostomia and related diseases such as hypertension, Parkinson’s disease, Sjogren’s syndrome, and diabetes has an affirmative influence on the global market. According to the industry reports, approximately 25 million individuals in the U.S. experience dry mouth.

Moreover, according to Sjogren Syndrome Foundation of America, approximately 4 million Americans are suffering Sjogren’s syndrome. Rising resourcefulness for the growth of awareness regarding xerostomia other factors expected to drive the Xerostomia Therapeutics Market growth. For instance, Sjogren Syndrome Foundation of America conducts wakefulness programs to support people suffering the syndrome in North America. In addition, the foundation introduced the ‘5-Year Breakthrough Goal’ in 2012 with an object to cure the xerostomia as well as decrease the time required to analyze it. Moreover, key players are focusing on acquiring developing establishments and conduct lineups to increase consciousness regarding xerostomia, further enhancing the market growth significantly.

Some major key players in Xerostomia Therapeutics Market include: -

• Eisai Inc.
• Colgate-Palmolive Company
• Dentaid
• EUSA Pharma
• Forward Science
• GlaxoSmithKline plc
• Mission Pharmacal Company
• OraHealth Inc.
• OraPharma Inc.
• Parnell Pharmaceuticals Inc.
• Saliwell Ltd.
• Sun Pharmaceutical Industries

For 'Queries' related to this research report, Make an Enquiry @
http://bit.ly/2PDiqIO

On the basis of product, the Xerostomia Therapeutics Market is segmented into Artificial Saliva, Dentifrices, Salivary Stimulants, Saliva Substitutes, Drugs, and Salivary Pen. On the basis of products, dentifrices segment is estimated to dominate the market. The dominance is primarily due to affordability, availability, effectiveness, higher adoption amongst the users.
On the basis of the distribution channel, the global xerostomia therapeutics market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. In 2017, the hospital pharmacy is anticipated to dominate the market. The dominance of hospital pharmacy is majorly due to the availability of limited branded drugs, safety & efficacy, safety, and low pricing of products.

Asia Pacific is anticipated to make a dominating growth for Xerostomia Therapeutics Market during the forecast period. growing healthcare spending, the rise in inventiveness for growing awareness, and increasing occurrence of ailments such as Parkinson’s disease, diabetes, cancer, and HIV causing dry mouth conditions and factors estimated to bolster the market in the Asia Pacific.

Table of Content of Xerostomia Therapeutics Market:

Chapter 1. Overview and Scope
Chapter 2. Market Summary
Chapter 3 Xerostomia Therapeutics Market Size and Forecast
Chapter 4. Dynamics and Segmentation
Chapter 5. Detailed Insight on Key Company
Chapter 6. Research Methodology and Reference
Chapter 7. Competitive Landscape
TOC Continued…...!!!

About Us:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:
Mr. Neel
Corporate Sales, USA
Polaris Market Research and Consulting
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Xerostomia Therapeutics Market to Show Significant Growth Along with Major Leading Players: Eisai Inc., Colgate-Palmolive Company, Dentaid, EUSA Pharma, Forward Science, GlaxoSmithKline plc and Mission Pharmacal Company here

News-ID: 1351580 • Views:

More Releases from Polaris Market Research & Consulting

North America Heat Transfer Fluids Market Estimated to hit USD 1,538.36 Million at a CAGR of 9.1% by year 2032-End
North America Heat Transfer Fluids Market Estimated to hit USD 1,538.36 Million …
New York, April 28, 2024 (Polaris Market Research) According to recent market analysis, the "North America Heat Transfer Fluids Market Share, Size, Trends, Industry Analysis Report, By Product Type (Silicones & Aromatics, Glycols, Mineral Oils, Others); End-Use; Country; Segment Forecast, 2024 - 2032" is expected to increase from USD 707.15 million in 2023 to USD 1,538.36 million by 2032, exhibiting a CAGR of 9.1% during the forecast period. Heat transfer fluids,
Asia Pacific Polyurethane Market Sets New Record, Projected at US$ 59.45 Billion by 2032 at 5.6% CAGR
Asia Pacific Polyurethane Market Sets New Record, Projected at US$ 59.45 Billion …
New York, April 28, 2024 (Polaris Market Research) According to a research report "Asia Pacific Polyurethane Market by Product (Rigid PU Foam, Flexible PU Foam, PU Coatings, PU Adhesives & Sealants, PU Elastomers), Application, Country - Global Forecast to 2032" published by Polaris Market Research, the market size for polyurethane in Asia Pacific is projected to reach approximately USD 59.45 billion by 2032, as compared to the estimated value of
Europe Transcritical CO2 Market Size to Hit US$ 94.20 Billion by 2032, Grow at a 15.3% CAGR
Europe Transcritical CO2 Market Size to Hit US$ 94.20 Billion by 2032, Grow at a …
New York, April 28, 2024 (Polaris Market Research) The Europe Transcritical CO2 Market, in terms of revenue, was estimated to be worth USD 26.26 billion in 2023 and is foreseen to reach USD 94.20 billion by 2032, growing at a CAGR of 15.3% from 2024 to 2032, according to a recent report by Polaris Market Research. Growing demand in the refrigeration industry for natural refrigerants and energy-efficient solutions is propelling
Asia Pacific Energy Drinks Market Exceed US$ 68.77 Billion and Exhibit at a CAGR of 7.4% in the Year 2032
Asia Pacific Energy Drinks Market Exceed US$ 68.77 Billion and Exhibit at a CAGR …
Asia Pacific Energy Drinks Market size and share is currently valued at USD 36.44 billion in 2023 and is anticipated to generate an estimated revenue of USD 68.77 Billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 7.4% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032 This is due to several factors, including growing

All 5 Releases


More Releases for Xerostomia

Xerostomia (Dry Mouth) Therapeutics Market Opportunities, Business Statistics Re …
The global xerostomia therapeutics market size is expected to reach USD 822.1 million by 2026 growing at a CAGR of 3.6% during the forecast period according to a new report published by Polaris Market Research. Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=31976 Some of the leading companies in this market include Colgate-Palmolive Company, EUSA Pharma, GlaxoSmithKline plc, Forward Science, Mission Pharmacal Company, Eisai Inc., Ora Health Inc., Parnell Pharmaceuticals, Inc., Ora
Global Xerostomia (Dry Mouth) Treatment Market Segmentation and Analysis Researc …
With recorded sales worth US$ 952.7 Bn in 2021, the global xerostomia (dry mouth) treatment market is expected to experience high growth over the coming years owing to increasing consumption of prescribed medicines globally. The xerostomia treatment market is estimated to expand at a CAGR of nearly 6.1% from 2022 to 2032. Xerostomia is commonly known as dry mouth that occurs as a result of decreased or missing saliva because of
Xerostomia Therapeutics Market Size - Forecasts to 2026
As per the research conducted by GME, the Xerostomia Therapeutics Market will grow with a CAGR value of 3.8 percent by 2026. Factors boosting demand growth include increasing prescription drug consumption, quick accessibility & cost-effectiveness of drugs, a rising elderly population demographic, and an uptick in the incidence of disorders such as Sjogren's syndrome, HIV, diabetes, and Alzheimer's disease, among others. Browse 151 Market Data Tables and 111 Figures spread through
Xerostomia - Market Insight, Epidemiology and Market Forecast - 2027
"Xerostomia - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Xerostomia epidemiology and market outlook for the 7MM. Markets Covered • United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Xerostomia Understanding and Treatment Algorithm The market report provides the overview of the Xerostomia by providing the disease overview, definition, classification, symptoms, etiology, pathophysiology and diagnostic methods. It also covers the detailed treatment approaches
Xerostomia Market: Global Market Capacity, Production, Revenue by Regions till 2 …
Xerostomia Market report gives a far reaching investigation of the Xerostomia the Research of disease transmission, giving the chronicled and forecasted information for the 7MM during the estimate time frame from 2016-2027. The report covers detailed overview of Xerostomia explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns, it also helps to recognize the growth opportunities in the 7MM with respect to the patient population. Get Sample PDF of Xerostomia
Xerostomia (Dry Mouth) Treatment Market Growth to be Stimulated by 2025
Xerostomia, commonly known as dry mouth, is defined as a condition resulting in the limited production of saliva or alteration in the saliva quality to retain the mouth wet. Xerostomia is normally caused due to a variety of factors such as side-effects from medication, dehydration, surgery, mouth bleeding, smoking, and irradiation of neck and head. The xerostomia is not classified as a disease but as symptoms of variable disorders. Xerostomia